Erratum: Implications of new Hypertension guidelines in the United States (Hypertension (2011) 58 (361-366) DOI: 10.1161/HYPERTENSIONAHA.111.175463);Implications of new hypertension guidelines in the united states

Hypertension

Volumn 58, Issue 3, 2011, Pages 361-366

  Bertoia, Monica L ^a,b   Waring, Molly E ^c   Gupta, Priya S ^a   Roberts, Mary B ^b   Eaton, Charles B ^a,b  

^a BROWN UNIVERSITY   (United States)

^b MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

CDC; Centers for Disease Control and Prevention; Hypertension; National Health and Nutrition Examination Study; NHANES; race; sex

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; AMERICAN FOULBROOD; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; EDUCATIONAL STATUS; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

EID: 80051952268     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYP.0b013e318269bc7a     Document Type: Erratum

References (28)

1. Glover M, Greenlund K, Ayala C, Croft J. Racial/ethnic disparities in prevalence, treatment, and control of hypertension: United States, 1999-2002. MMWR Morb Mortal Wkly Rep. 2005;54:7-9.
2. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003; 290:199-206. (Pubitemid 37430058)
3. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med. 2004;164: 2126-2134. (Pubitemid 39410802)
4. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49:69-75. (Pubitemid 46360343)
5. Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006;47: 296-308. (Pubitemid 43189776)
6. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913. (Pubitemid 35472129)
7. Sipahi I, Tuzcu EM, Schoenhagen P, Wolski KE, Nicholls SJ, Balog C, Crowe TD, Nissen SE. Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis. J Am Coll Cardiol. 2006;48:833-838. (Pubitemid 44175741)
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42: 1206-1252. (Pubitemid 37553153)
9. Rosendorff C, Black HR, Cannon CP, Gersh BJ, Core J, Izzo JL Jr, Kaplan NM, O'Connor CM, O'Gara PT, Oparil S. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation. 2007;115:2761-2788. (Pubitemid 46842793)
10. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43:S1-290.
11. Arauz-Pacheco C, Parrott MA, Raskin P. Treatment of hypertension in adults with diabetes. Diabetes Care. 2003;26:S80-S82. (Pubitemid 36928963)
12. National Center for Health Statistics. National Health and Nutrition Examination Survey. 2010.
13. Perloff D, Grim C, Flack J, Frohlick ED, Hill M, McDonald M, Morgenstern BZ. Human blood pressure determination by sphygmomanometry. Circulation. 1993;88:2460-2470.
14. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension. 2008;52:818-827.
15. National Institutes of Health, National Heart Lung and Blood Institute. ATP III Guidelines At-A-Glance Quick Desk Reference. National Institutes of Health, National Heart Lung and Blood Institute; 2001.
16. Moses S. Creatinine clearance. In: Family Practice Notebook. 2009.
17. Russ A. Drug Pocket: Clinical Reference Guide. 3rd ed. Hermosa Beach, CA: Borm Bruckmeier Publishing LLC; 2004.
18. National Center for Health Statistics. The National Health and Nutrition Examination Survey (NHANES): analytic and reporting guidelines. National Center for Health Statistics; 2005.
19. Research Triangle Institute. SUDAAN Language Manual, Release 9. 1st ed. Research Triangle Park, NC: Research Triangle Institute; 2004.
20. Ostchega Y, Dillon CF, Hughes JP, Carroll M, Yoon S. Trends in hypertension prevalence, awareness, treatment, and control in older US adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc. 2007;55:1056-1065. (Pubitemid 47024610)
21. He J, Muntner P, Chen J, Roccella EJ, Streiffer RH, Whelton PK. Factors associated with hypertension control in the general population of the United States. Arch Intern Med. 2002;162:1051-1058. (Pubitemid 34492536)
22. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479-486. (Pubitemid 32758499)
23. Peralta CA, Hicks LS, Chertow GM, Ayanian JZ, Vittinghoff E, Lin F, Shlipak MG. Control of hypertension in adults with chronic kidney disease in the United States. Hypertension. 2005;45:1119-1124. (Pubitemid 40770315)
24. Duru OK, Vargas RB, Kermah D, Pan D, Norris KC. Health insurance status and hypertension monitoring and control in the United States. Am J Hypertens. 2007;20:348-353. (Pubitemid 46441764)
25. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 303: 2043-2050.
26. Gandelman G, Aronow WS, Varma R. Prevalence of adequate blood pressure control in self-pay or Medicare patients versus Medicaid or private insurance patients with systemic hypertension followed in a university cardiology or general medicine clinic. Am J Cardiol. 2004;94: 815-816. (Pubitemid 39221512)
27. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J, Roger VL, Turner MB. Executive summary: heart disease and stroke statistics: 2011 update-a report from the American Heart Association. Circulation. 123:459-463.
28. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, Black HR, Grimm RH Jr, Messerli FH, Oparil S, Schork MA. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006;354:1685-1697.